Literature DB >> 15486845

Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy.

Lynda Anne Szczech1, Donald R Hoover, Joseph G Feldman, Mardge H Cohen, Stephen J Gange, Lisa Goozé, Nancy R Rubin, Mary A Young, Xiaotao Cai, Qiuhu Shi, Wei Gao, Kathryn Anastos.   

Abstract

BACKGROUND: The associations of proteinuria and an elevated creatinine level with progression to acquired immunodeficiency syndrome (AIDS) and death in the era of highly antiretroviral therapy (HAART) have not been fully described.
METHODS: This analysis includes 2038 human immunodeficiency virus (HIV)-infected women from the Women's Interagency HIV Study. Time to the development of a new AIDS-defining illness (ADI) and death was modeled using proportional hazards regression before the widespread availability of HAART and after initiation of HAART.
RESULTS: Of the 2038 subjects, the 14.1% of women with proteinuria had lower CD4 lymphocyte counts and higher viral loads (P<.0001 for all) at baseline and before initiation of HAART. Before the widespread availability of HAART, proteinuria was associated with an increased risk for development of ADI (hazard ratio [HR], 1.37; P=.005), and proteinuria and an elevated creatinine level were both associated with an increased risk of death (for proteinuria: HR, 1.35 [P=.04]; for creatinine: HR, 1.72 per decrease in the inverse unit [P=.02]). Among women initiating HAART, an elevated creatinine level remained associated with an increased risk of development of ADI (HR, 1.54 per decrease in the inverse unit; P=.03), and proteinuria and an elevated creatinine level were associated with an increased risk of death (for proteinuria: HR, 2.07 [P=.005]; for creatinine: HR, 1.96 per decrease in the inverse unit [P=.04]).
CONCLUSIONS: Proteinuria and an elevated creatinine level were associated with an increased risk of death and development of ADI. These associations may reflect the direct role of the kidney in modulating HIV disease, or they may act as markers of greater comorbidity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486845     DOI: 10.1086/424013

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  76 in total

1.  The morbidity and mortality associated with kidney disease in an HIV-infected cohort in Puerto Rico.

Authors:  Angel M Mayor; Mark Dworkin; Luis Quesada; Eddy Ríos-Olivares; Robert F Hunter-Mellado
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

2.  Relationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infection.

Authors:  Takashi Shinha; Deming Mi; Ziyue Liu; Christie M Orschell; Michael M Lederman; Samir K Gupta
Journal:  AIDS Res Hum Retroviruses       Date:  2015-02-26       Impact factor: 2.205

3.  Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.

Authors:  Alison G Abraham; Annie Darilay; Heather McKay; Joseph B Margolick; Michelle M Estrella; Frank J Palella; Robert Bolan; Charles R Rinaldo; Lisa P Jacobson
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

Review 4.  Screening for chronic kidney disease in HIV-infected patients.

Authors:  Michelle M Estrella; Derek M Fine
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

5.  The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial.

Authors:  Samir K Gupta; Robert A Parker; Gregory K Robbins; Michael P Dubé
Journal:  Nephrol Dial Transplant       Date:  2005-08-16       Impact factor: 5.992

6.  Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.

Authors:  Clara Y Jones; Camille A Jones; Ira B Wilson; Tamsin A Knox; Andrew S Levey; Donna Spiegelman; Sherwood L Gorbach; Frederick Van Lente; Lesley A Stevens
Journal:  Am J Kidney Dis       Date:  2008-05-02       Impact factor: 8.860

Review 7.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Racial differences in chronic kidney disease incidence and progression among individuals with HIV.

Authors:  Deidra C Crews; Bernard G Jaar
Journal:  Nat Clin Pract Nephrol       Date:  2008-09-23

Review 9.  The pharmacologic management of insomnia in patients with HIV.

Authors:  Toma S Omonuwa; Harold W Goforth; Xavier Preud'homme; Andrew D Krystal
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

10.  Microalbuminuria predicts overt proteinuria among patients with HIV infection.

Authors:  L A Szczech; P Menezes; E Byrd Quinlivan; C van der Horst; J A Bartlett; L P Svetkey
Journal:  HIV Med       Date:  2010-01-04       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.